Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Centromere protein E as a novel biomarker and potential therapeutic target for retinoblastoma

1 Jan 2021

Abstract excerpt

Retinoblastoma is the most common intraocular malignancy during childhood. Currently, there is no effective treatment for metastatic retinoblastoma. We investigated potential biomarkers of retinoblastoma by utilizing three datasets from a public database. Functional enrichment analysis, including gene ontology, Kyoto encyclopedia of genes and genomes, gene set enrichment analysis and variation analysis, suggested...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Ocular Oncology and Treatments
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34482803
DOI: 10.1080/21655979.2021.1972080

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Centromere protein E as a novel biomarker and potential therapeutic target for retinoblastomaPMID 34482803Read ↗

Integrative bioinformatics analysis for identification of hub genes and pathways responsible for early pathogenesis of retinoblastomaSemantic proximity Read ↗

E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma.Semantic proximity Read ↗

Significance of centromere protein genes and their associated immune and metabolic differences in the prediction of prognosis and treatment outcome in breast cancerSemantic proximity Read ↗

Update on pathology of retinoblastomaSemantic proximity Read ↗

Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastomaSemantic proximity Read ↗

CENPN Acts as a Novel Biomarker that Correlates With the Malignant Phenotypes of Glioma CellsSemantic proximity Read ↗

Integrated Epigenetic and Transcriptomic Profiling Reveals Dynamic Regulatory Networks Driving Retinoblastoma PathogenesisSemantic proximity Read ↗

The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple FrontsSemantic proximity Read ↗

Biomarkers in retinoblastomaSemantic proximity Read ↗

Twists in views on RB functions in cellular signaling, metabolism and stem cells.Semantic proximity Read ↗

Comprehensive Analysis of the Immune Cell Infiltration Landscape and Immune-Related Methylation in RetinoblastomaSemantic proximity Read ↗

Functional genomics identifies new synergistic therapies for retinoblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.